US Stock MarketDetailed Quotes

TNYA Tenaya Therapeutics

Watchlist
  • 1.515
  • -0.095-5.90%
Trading Dec 27 14:04 ET
120.02MMarket Cap-1.05P/E (TTM)

Tenaya Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-13.61%26.71M
-12.20%30.82M
0.12%33.76M
4.44%131.19M
-8.98%31.45M
-1.21%30.92M
22.66%35.1M
8.25%33.72M
72.54%125.62M
32.05%34.55M
Selling and administrative expenses
-18.75%6.36M
-5.25%8.17M
7.26%8.71M
6.66%33.16M
-2.51%8.58M
3.83%7.83M
11.42%8.63M
15.99%8.12M
68.82%31.08M
68.91%8.8M
-General and administrative expense
-18.75%6.36M
-5.25%8.17M
7.26%8.71M
6.66%33.16M
-2.51%8.58M
3.83%7.83M
11.42%8.63M
15.99%8.12M
68.82%31.08M
68.91%8.8M
Research and development costs
-11.87%20.35M
-14.46%22.65M
-2.15%25.06M
3.70%98.04M
-11.20%22.87M
-2.81%23.09M
26.83%26.48M
6.00%25.61M
73.80%94.54M
22.88%25.75M
Operating profit
13.61%-26.71M
12.20%-30.82M
-0.12%-33.76M
-4.44%-131.19M
8.98%-31.45M
1.21%-30.92M
-22.66%-35.1M
-8.25%-33.72M
-72.54%-125.62M
-32.05%-34.55M
Net non-operating interest income expense
-39.19%1.08M
-24.17%1.39M
-26.41%1.45M
261.11%7.06M
41.76%1.47M
197.99%1.78M
727.48%1.84M
1,892.93%1.97M
1,709.26%1.95M
1,447.76%1.04M
Non-operating interest income
-39.19%1.08M
-24.17%1.39M
-26.41%1.45M
261.11%7.06M
41.76%1.47M
197.99%1.78M
727.48%1.84M
1,892.93%1.97M
1,709.26%1.95M
1,447.76%1.04M
Other net income (expense)
-400.00%-3K
50.00%-1K
530.77%82K
2,550.00%53K
1,466.67%41K
-83.33%1K
-2K
1,400.00%13K
108.70%2K
94.44%-3K
Other non- operating income (expenses)
-400.00%-3K
50.00%-1K
530.77%82K
2,550.00%53K
1,466.67%41K
-83.33%1K
---2K
1,400.00%13K
108.70%2K
94.44%-3K
Income before tax
12.04%-25.63M
11.54%-29.43M
-1.55%-32.23M
-0.34%-124.08M
10.68%-29.94M
5.06%-29.14M
-17.16%-33.27M
-2.19%-31.74M
-70.05%-123.67M
-28.16%-33.52M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
12.04%-25.63M
11.54%-29.43M
-1.55%-32.23M
-0.34%-124.08M
10.68%-29.94M
5.06%-29.14M
-17.16%-33.27M
-2.19%-31.74M
-70.05%-123.67M
-28.16%-33.52M
Net income continuous Operations
12.04%-25.63M
11.54%-29.43M
-1.55%-32.23M
-0.34%-124.08M
10.68%-29.94M
5.06%-29.14M
-17.16%-33.27M
-2.19%-31.74M
-70.05%-123.67M
-28.16%-33.52M
Minority interest income
Net income attributable to the parent company
12.04%-25.63M
11.54%-29.43M
-1.55%-32.23M
-0.34%-124.08M
10.68%-29.94M
5.06%-29.14M
-17.16%-33.27M
-2.19%-31.74M
-70.05%-123.67M
-28.16%-33.52M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
12.04%-25.63M
11.54%-29.43M
-1.55%-32.23M
-0.34%-124.08M
10.68%-29.94M
5.06%-29.14M
-17.16%-33.27M
-2.19%-31.74M
-70.05%-123.67M
-28.16%-33.52M
Basic earnings per share
23.08%-0.3
24.44%-0.34
6.98%-0.4
39.13%-1.68
34.43%-0.4
47.30%-0.39
34.78%-0.45
42.67%-0.43
32.68%-2.76
3.17%-0.61
Diluted earnings per share
23.08%-0.3
24.44%-0.34
6.98%-0.4
39.13%-1.68
34.43%-0.4
47.30%-0.39
34.78%-0.45
42.67%-0.43
32.68%-2.76
3.17%-0.61
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -13.61%26.71M-12.20%30.82M0.12%33.76M4.44%131.19M-8.98%31.45M-1.21%30.92M22.66%35.1M8.25%33.72M72.54%125.62M32.05%34.55M
Selling and administrative expenses -18.75%6.36M-5.25%8.17M7.26%8.71M6.66%33.16M-2.51%8.58M3.83%7.83M11.42%8.63M15.99%8.12M68.82%31.08M68.91%8.8M
-General and administrative expense -18.75%6.36M-5.25%8.17M7.26%8.71M6.66%33.16M-2.51%8.58M3.83%7.83M11.42%8.63M15.99%8.12M68.82%31.08M68.91%8.8M
Research and development costs -11.87%20.35M-14.46%22.65M-2.15%25.06M3.70%98.04M-11.20%22.87M-2.81%23.09M26.83%26.48M6.00%25.61M73.80%94.54M22.88%25.75M
Operating profit 13.61%-26.71M12.20%-30.82M-0.12%-33.76M-4.44%-131.19M8.98%-31.45M1.21%-30.92M-22.66%-35.1M-8.25%-33.72M-72.54%-125.62M-32.05%-34.55M
Net non-operating interest income expense -39.19%1.08M-24.17%1.39M-26.41%1.45M261.11%7.06M41.76%1.47M197.99%1.78M727.48%1.84M1,892.93%1.97M1,709.26%1.95M1,447.76%1.04M
Non-operating interest income -39.19%1.08M-24.17%1.39M-26.41%1.45M261.11%7.06M41.76%1.47M197.99%1.78M727.48%1.84M1,892.93%1.97M1,709.26%1.95M1,447.76%1.04M
Other net income (expense) -400.00%-3K50.00%-1K530.77%82K2,550.00%53K1,466.67%41K-83.33%1K-2K1,400.00%13K108.70%2K94.44%-3K
Other non- operating income (expenses) -400.00%-3K50.00%-1K530.77%82K2,550.00%53K1,466.67%41K-83.33%1K---2K1,400.00%13K108.70%2K94.44%-3K
Income before tax 12.04%-25.63M11.54%-29.43M-1.55%-32.23M-0.34%-124.08M10.68%-29.94M5.06%-29.14M-17.16%-33.27M-2.19%-31.74M-70.05%-123.67M-28.16%-33.52M
Income tax 0000000000
Net income 12.04%-25.63M11.54%-29.43M-1.55%-32.23M-0.34%-124.08M10.68%-29.94M5.06%-29.14M-17.16%-33.27M-2.19%-31.74M-70.05%-123.67M-28.16%-33.52M
Net income continuous Operations 12.04%-25.63M11.54%-29.43M-1.55%-32.23M-0.34%-124.08M10.68%-29.94M5.06%-29.14M-17.16%-33.27M-2.19%-31.74M-70.05%-123.67M-28.16%-33.52M
Minority interest income
Net income attributable to the parent company 12.04%-25.63M11.54%-29.43M-1.55%-32.23M-0.34%-124.08M10.68%-29.94M5.06%-29.14M-17.16%-33.27M-2.19%-31.74M-70.05%-123.67M-28.16%-33.52M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 12.04%-25.63M11.54%-29.43M-1.55%-32.23M-0.34%-124.08M10.68%-29.94M5.06%-29.14M-17.16%-33.27M-2.19%-31.74M-70.05%-123.67M-28.16%-33.52M
Basic earnings per share 23.08%-0.324.44%-0.346.98%-0.439.13%-1.6834.43%-0.447.30%-0.3934.78%-0.4542.67%-0.4332.68%-2.763.17%-0.61
Diluted earnings per share 23.08%-0.324.44%-0.346.98%-0.439.13%-1.6834.43%-0.447.30%-0.3934.78%-0.4542.67%-0.4332.68%-2.763.17%-0.61
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
+0.26%
Petroleo Brasileiro SA Petrobras
PBR
-0.05%
Vale SA
VALE
-0.61%
D.R. Horton
DHI
-0.86%
Lennar Corp
LEN
-0.90%

Unlock the Full List